lamotrigine sold brand name lamictal among others medication used treat epilepsy stabilize mood bipolar epilepsy includes focal seizures tonicclonic seizures seizures lennoxgastaut bipolar disorder lamotrigine shown reliably treat acute depression patients bipolar disorder currently symptomatic appears effective reducing risk future episodes common side effects include nausea sleepiness headache vomiting trouble coordination serious side effects include excessive breakdown red blood cells increased risk suicide severe skin reaction syndrome allergic reactions lamotrigine phenyltriazine making chemically different mechanism action clear appears inhibit release excitatory neurotransmitters via voltagesensitive sodium channels voltagegated calcium channels lamotrigine first marketed ireland approved use united states world health organizations list essential commonly prescribed medication united states million lamotrigine considered firstline drug primary generalized tonicclonic seizures includes simple partial complex partial secondarily generalized seizures focalonset tonicclonic seizures also used alternative adjuvant medication partial seizures absence seizure myoclonic seizure atonic review use lamotrigine addon therapy drug resistant generalized tonicclonic seizures unable come conclusions inform clinical practice although lowcertainty evidence suggest reduces generalized tonicclonic seizures level uncertainty indicates actual findings could significantly another cochrane review examining use lamotrigine addon therapy drugresistant focal epilepsy found effective reducing seizure frequency well lamotrigine one small number fdaapproved therapies form epilepsy known reduces frequency lgs seizures one two medications known decrease severity drop combination valproate common increases risk lamotrigineinduced severe skin reaction syndrome necessitates reduced dosing due interaction lamotrigine approved us maintenance treatment bipolar disorder bipolar ii anticonvulsants carbamazepine valproate predominantly antimanics lamotrigine demonstrated efficacy preventing reducing risk recurrent depressive episodes bipolar disorder drug seems ineffective treatment current rapidcycling acute mania acute depression bipolar lamotrigine shown effective lithium standard treatment bipolar lamotrigine demonstrated clear efficacy treating acute mood episodes either mania depression demonstrated effectiveness treating acute controversy regarding drugs effectiveness treating acute bipolar paper written nassir et al reviewed evidence trials unpublished referenced apa guidelines concludes lamotrigine limited efficacy treatment acute bipolar paper calabrese et al examined much data found five placebocontrolled studies lamotrigine significantly differ placebo treatment bipolar however metaanalysis studies conducted geddes calabrese goodwin found lamotrigine effective individuals bipolar depression number needed treat nnt severe review concluded lamotrigine recommended bipolar maintenance depression prominent research needed regard role treatment acute bipolar depression unipolar depression information recommend use psychiatric disorders lamotrigine monotherapy substantially effective schizophrenia however various expressed lamotrigine could added clozapine augmentation therapy partial nonresponding schizophrenic patients patients statistically significant improvements positive negative affective symptoms lamotrigine statistically significant effect antipsychotics clozapine olanzapine risperidone haloperidol zuclopenthixol offlabel uses include treatment peripheral neuropathy trigeminal neuralgia cluster headaches migraines visual snow reducing neuropathic although systematic review conducted concluded welldesigned clinical trials shown benefit lamotrigine neuropathic offlabel psychiatric usage includes treatment treatmentresistant obsessivecompulsive depersonalization hallucinogen persisting perception schizoaffective borderline personality shown useful posttraumatic stress glaxosmithkline investigated lamotrigine treatment adhd inconclusive results detrimental effects cognitive function observed however statistical improvement core adhd symptoms improvement paced auditory serial addition test measures auditory processing speed calculation another study reported lamotrigine might safe effective treatment option adult adhd comorbid bipolar recurrent side effects rash fever fatigue serious may indicate incipient sjs ten dress syndrome aseptic lamotrigine prescribing information black box warning lifethreatening skin reactions including syndrome sjs dress syndrome toxic epidermal necrolysis manufacturer states nearly cases appear first two eight weeks patients seek medical attention unexpected skin rash presence indication possible serious even deadly side effect drug rashes occur taking lamotrigine progress sjs ten patients develop rash one thousand patients develop serious rash rash skin reactions common children medication often reserved adults patients whose lamotrigine stopped development rash rechallenge lamotrigine also viable option however applicable serious incidence eruptions increases patients currently recently discontinued valproatetype anticonvulsant drug medications interact way clearance decreased effective dose lamotrigine fda required new warning risk hemophagocytic lymphohistiocytosis serious reaction occur days weeks starting side effects include alopecia hair loss loss balance coordination double vision crossed eyes pupil constriction blurred vision dizziness lack coordination drowsiness insomnia anxiety vivid dreams nightmares dry mouth mouth ulcers memory problems mood changes itchiness runny nose cough nausea indigestion abdominal pain weight loss missed painful menstrual periods vaginitis sideeffects profile varies different patient overall adverse effects treatment similar men women geriatric pediatric racial systematic review literature revealed abnormal movements secondary lamotrigine uncommon movement disorders associated lamotrigine tics akathisias dyskinesias myoclonus parkinsonism dystonia cerebellar syndromes lamotrigine associated decrease white blood cell count lamotrigine prolong qtqtc tqt studies healthy people taking antipsychotics cases lamotrigineprecipitated neuroleptic malignant syndrome women likely men side evidence shows interactions lamotrigine female hormones particular concern women estrogencontaining hormonal contraceptives ethinylestradiol ingredient contraceptives shown decrease serum levels women starting estrogencontaining oral contraceptive may need increase dosage lamotrigine maintain level efficacy likewise women may experience increase lamotrigine side effects upon discontinuation birth control pills may include pillfree week lamotrigine serum levels shown increase many studies found association lamotrigine exposure utero birth defects found association found slight associations minor malformations cleft review studies found overall rates congenital malformations infants exposed lamotrigine utero relatively low similar rate malformations general known lamotrigine weak inhibitor human dihydrofolate reductase dhfr powerful human dhfr inhibitors methotrexate known lamotrigine expressed breast milk manufacturer recommends carefully weighing benefits risks taking lamotrigine however studies suggest lamotrigine safe use frequently updated review scientific literature rates lamotrigine moderately lamotrigine binds melanincontaining tissues iris eye melaninrich skin longterm consequences lamotrigine known affect sleep studies small numbers patients reported lamotrigine increases duration rem sleep decreases number phase shifts decreases duration slowwave effect daytime somnolence cognitive however retrospective study patients medical records found patients experienced alerting effect resulting intolerable insomnia treatment lamotrigine induce type seizure known myoclonic jerk tends happen soon use used treatment myoclonic epilepsies juvenile myoclonic epilepsy lower doses lower plasma levels usually needed even moderate doses drug induce seizures including tonicclonic seizures develop status epilepticus medical emergency also cause myoclonic status overdose lamotrigine cause uncontrolled seizures people reported results overdoses involving g include increased seizures coma lamotrigine member sodium channel blocking class antiepileptic may suppress release glutamate aspartate two dominant excitatory neurotransmitters central nervous generally accepted member sodium channel blocking class antiepileptic could additional actions since broader spectrum action sodium channel antiepileptic drugs phenytoin effective treatment depressed phase bipolar disorder whereas sodium channelblocking antiepileptic drugs possibly account sigma receptor activity addition lamotrigine shares side effects unrelated anticonvulsants known inhibit sodium channels emphasizes unique triazine derivate inhibits voltagesensitive sodium channels leading stabilization neuronal membranes also blocks l n ptype calcium channels weakly inhibits serotonin actions thought inhibit release glutamate cortical projections ventral striatum limbic neuroprotective antiglutamatergic effects pointed promising contributors mood stabilizing observations lamotrigine reduced Î³aminobutyric acid gaba receptormediated neurotransmission rat amygdala suggest gabaergic mechanism may also appears lamotrigine increase gaba blood levels lamotrigine pronounced effects usual neurotransmitter receptors anticonvulsants affect adrenergic dopamine muscarinic gaba histaminergic serotonin nmethyldaspartate inhibitory effects norepinephrine dopamine transporters lamotrigine weak inhibitor dihydrofolate whether effect sufficient contribute mechanism action increases risk fetus pregnancy known early studies lamotrigines mechanism action examined effects release endogenous amino acids rat cerebral cortex slices vitro case antiepileptic drugs act voltagedependent sodium channels lamotrigine thereby inhibits release glutamate aspartate evoked sodiumchannel activator veratrine less effective inhibition acetylcholine gaba release high concentrations effect spontaneous potassiumevoked amino acid studies suggested lamotrigine acts presynaptically voltagegated sodium channels decrease glutamate release several electrophysiological studies investigated effects lamotrigine voltagegated sodium channels example lamotrigine blocked sustained repetitive firing cultured mouse spinal cord neurons concentrationdependent manner concentrations therapeutically relevant treatment human seizures cultured hippocampal neurons lamotrigine reduced sodium currents voltagedependent manner depolarised potentials showed small frequencydependent inhibition variety results indicate antiepileptic effect lamotrigine like phenytoin carbamazepine least part due use voltagedependent modulation fast voltagedependent sodium currents however lamotrigine broader clinical spectrum activity phenytoin carbamazepine recognised protective generalised absence epilepsy generalised epilepsy syndromes including primary generalised seizures juvenile myoclonic epilepsy lennoxgastaut syndrome basis broader spectrum activity lamotrigine unknown could relate actions drug voltagegated calcium channels lamotrigine blocks ttype calcium channels weakly however inhibit native recombinant high calcium channels n pqrtypes therapeutic concentrations whether activity calcium channels accounts lamotrigines broader clinical spectrum activity comparison phenytoin carbamazepine remains determined antagonises receptors following pharmacokinetics lamotrigine follow firstorder kinetics halflife hours volume distribution lamotrigine rapidly completely absorbed oral administration absolute bioavailability plasma cmax occurs hours available data indicate bioavailability affected food estimate mean apparent volume distribution lamotrigine following oral administration ranges lkg independent dose similar following single multiple doses patients epilepsy healthy lamotrigine inactivated glucuronidation lamotrigine metabolized predominantly glucuronic acid conjugation major metabolite inactive lamotrigine fewer drug interactions many anticonvulsant drugs although pharmacokinetic interactions carbamazepine phenytoin hepatic enzyme inducing medications may shorten dose adjustments made clinical response monitoring may benefit assessing capacity available tests detect potentially adverse consequences melanin binding unknown clinical trials excluded subtle effects optimal duration treatment specific recommendations periodic ophthalmological monitoring lamotrigine binds eye melanincontaining tissues accumulate time may cause toxicity prescribers aware possibility longterm ophthalmologic effects base treatment clinical response patient compliance periodically reassessed lab medical testing liver kidney function monitor progress side first synthesis lamotrigine disclosed patent filed wellcome foundation chloride treated cuprous cyanide form acyl cyanide reacted nitrate salt aminoguanidine give intermediate cyclised diamino triazine drug lamotrigine sold original brand name available generic form many brand names march united states food drug administration fda issued warning regarding potential cardiac arrhythmias people preexisting structural conduction heart warning provoked consternation controversy within professional invitro study conducted predicted class ib antiarrhythmic activity therapeutic concentrations lamotrigine due sodium channelblocking thus lamotrigine use atrisk populations could prolong qrs interval electrocardiogram increase risk arrhythmias sudden death references human studies postmarket data atrisk populations ie people structural heart disease cited support warning study dogs mentioned prescribing information brochure rapid systematic review concluded insufficient evidence support refute lamotrigine associated sudden death electrocardiogram fda recommended studies conducted lamotrigine sodiumchannel blocking antiseizure march faers fda adverse event reporting system analysis demonstrated signals cardiac arrest tachyarrhythmia bradyarrhythmia clinical manifestation fainting lamotrigine study stratified epileptic psychiatric indications explaining nature signal cardiac arrest seems confounded psychiatric indication included times concomitant medications cardiac adverse events qtprolonging drugs additionally greater reports overdose suicide attempts recorded psychiatric reports although lamotrigine blocks cardiac sodium channels therapeutically relevant concentrations owing shortfast kinetics channel level blockage translate disproportionality signal though lamotrigine used treat seizures infants effectiveness age group evaluated one study adverse effects rarely severe enough medication discontinued age group however effectiveness reducing seizures httpsenwikipediaorgwikilamotrigine